Vosaroxin Completed Phase 1 Trials for Leukemia, Nonlymphocytic, Acute / Chronic Myeloid Leukemia (CML) / Leukemia, Lymphocytic, Acute / Myelodysplastic Syndromes (MDS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00246662Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies